Tag: opioid epidemic

CDC Director Says There are More Suicides and Overdoses than COVID Deaths

Center for Disease Control Director Robert Redfield testified in a Buck Institute webinar that suicides and drug overdoses have surpassed the death rate for COVID-19. Redfield argued that lockdowns and lack of public schooling constituted a disproportionally negative impact on young peoples’ mental health.

“We’re seeing, sadly, far greater suicides now than we are deaths from COVID. We’re seeing far greater deaths from drug overdose that are above excess that we had as background than we are seeing the deaths from COVID,” he said.

Roughly 146,000 people have died from COVID or COVID-related causes in the U.S., according to CDC data.

The most recent publicized federal data records 48,000 deaths from suicide and at least 1.4 million attempts in 2018. In 2019, almost 71,000 people died from drug overdoses.

Where Redfield obtained his data is unknown, although a doctor at John Muir Medical Center in Walnut Creek, CA claimed the facility has “seen a year’s worth of suicide attempts in the last four weeks.” He did not say how many deaths occurred, or whether the statement was exaggerated for emphasis.

Keep reading

Ibogaine May Help Us Better Understand Substance Use Disorders, but Will it Solve the Opioid Crisis?

Among the drugs used in withdrawal treatments, ibogaine is unique. Most substances administered to patients in rehab are intended to temporarily allay withdrawal pains. The name of the practice, “substitution therapy,” already implies its flaws (ones with which Juliana was well acquainted). Ibogaine treatment, in contrast, goes after the addiction itself. It puts people into what’s often described as a “waking dream” state, with effects lasting for more than 10 hours.

“It’s not a hallucinogen like LSD. It’s not like you’re sitting there awake watching the trails on the wall,” describes Dana Beal, one of the world’s leading ibogaine activists who has experienced the effects of ibogaine firsthand. “You close your eyes and go into a waking dream. You’re paralyzed because you can’t summon the will to move. You just want to lie in a quiet room, left alone to review your lifetime of memories.”

In one small study, published in The American Journal of Drug and Alcohol Abuse in 2018, 50 percent of patients reported not using opioids in the previous 30 days at the three-month check-up following their ibogaine treatment. In comparison, says Ken Alper, associate professor of psychiatry and neurology at NYU School of Medicine, one-third to half of patients fail to even complete detoxification treatment using methadone, buprenorphine, and klonopin, today’s three most common drugs for opioid withdrawal symptoms. Among the people who do complete detoxification with these drugs, roughly half are still sober after four to five months.

“[Ibogaine] is the anti-drug,” says Beal, who along with researchers Howard Lotsof and Norma Alexander, studied ibogaine’s therapeutic effects. “You come out and you don’t want to do any more ibogaine, and you don’t want to do a lot of drugs after taking ibogaine.”

Keep reading